|
|
||||||||
RESEARCH REPORT |
Department of Orthodontics, College of Dentistry, University of Florida, Box 100444, JHMHC, Gainesville, FL 32610-0444;
* corresponding author, cdolce{at}dental.ufl.edu
We tested whether orthodontic tooth movement (OTM) could be blocked by local administration of echistatin or an arginine-glycine-aspartic acid (RGD) peptide, agents known to perturb bone remodeling, adjacent to maxillary molars in rats. These molecules were incorporated into ethylene-vinyl acetate (ELVAX), a non-biodegradable, sustained-release polymer. In vitro experiments showed that the echistatin and RGD peptide were released from ELVAX in active forms at levels sufficient to disrupt osteoclasts. Biotinylated RGD peptide was released from ELVAX into the PDL after surgical implantation. ELVAX loaded with either RGD peptide or echistatin and surgically implanted next to the maxillary molars inhibited orthodontic tooth movement (p < 0.01). The RGD peptide also reduced molar drift (p < 0.05). This study shows the feasibility of using ELVAX to deliver integrin inhibitors adjacent to teeth to limit local tooth movement in response to orthodontic forces.
KEY WORDS: integrins orthodontic tooth movement echistatin RGD
This article has been cited by other articles:
![]() |
G.E. Wise and G.J. King Mechanisms of Tooth Eruption and Orthodontic Tooth Movement J. Dent. Res., May 1, 2008; 87(5): 414 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zuo, L.A. Archer, A. Cooper, K.L. Johnson, L.S. Holliday, and C. Dolce Nuclear Factor {kappa}B p65 Phosphorylation in Orthodontic Tooth Movement J. Dent. Res., June 1, 2007; 86(6): 556 - 559. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |